AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28731602 — intervention group
Group type: EXPERIMENTAL
Intervention: Frassetto et al. equation two
Number of subjects: 13
Study 26284393 — intervention group
Group type: EXPERIMENTAL
Intervention: 'Sandwich' urethra reconstruction
Number of subjects: 71
Study 26284393 — intervention group
Group type: COMPARATOR
Intervention: No reconstruction (Control)
Number of subjects: 71
Study 24002280 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP) with iron (12.5 mg/d of iron)
Number of subjects: 1958
Study 24002280 — intervention group
Group type: COMPARATOR
Intervention: Micronutrient powder (MNP) without iron
Number of subjects: 1958
Study 21235310 — intervention group
Group type: EXPERIMENTAL
Intervention: Open shunts
Number of subjects: 14
Study 21235310 — intervention group
Group type: COMPARATOR
Intervention: Closed shunts (initially ligated)
Number of subjects: 14
Study 19026262 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic‐Focused Psychodynamic Therapy (PFPP)
Number of subjects: 49
Study 19026262 — intervention group
Group type: COMPARATOR
Intervention: Applied Relaxation Therapy (ART)
Number of subjects: 49
Study 16765144 — intervention group
Group type: EXPERIMENTAL
Intervention: Palifermin 60 mug/kg
Number of subjects: 0
Study 16765144 — intervention group
Group type: EXPERIMENTAL
Intervention: Palifermin 120 mug/kg
Number of subjects: 0
Study 16765144 — intervention group
Group type: EXPERIMENTAL
Intervention: Palifermin 250 mug/kg
Number of subjects: 0
Study 16765144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15607390 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (Taxus)
Number of subjects: 48
Study 15607390 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 48
Study 11265777 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin
Number of subjects: 64
Study 11265777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 9236434 — intervention group
Group type: EXPERIMENTAL
Intervention: RheothRx (poloxamer 188)
Number of subjects: 2948
Study 7955819 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol infusion (0.0025 to 0.01 micrograms/kg/min) with ganglionic blockade (trimethaphan) in young subjects
Number of subjects: 29
Study 7955819 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol infusion (0.005 to 0.03 micrograms/kg/min) without ganglionic blockade
Number of subjects: 29
Study 7955819 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol infusion
Number of subjects: 29
Study 3612344 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (mailings of information, appointment reminders, intense follow-up by telephone)
Number of subjects: 854
Study 3612344 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 854
Study 3612344 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 854
Study 31855875 — intervention group
Group type: EXPERIMENTAL
Intervention: NCRT plus surgery (S)
Number of subjects: 389
Study 31855875 — intervention group
Group type: EXPERIMENTAL
Intervention: NCRT
Number of subjects: 389
Study 31764068 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 2394
Study 31764068 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 2394
Study 31764068 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo arm of VOICE trial
Number of subjects: 2394
Study 29933006 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal™ (SBU, 3 M) with self‐etch (SE)
Number of subjects: 22
Study 29933006 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal™ (SBU, 3 M) with etch-and-rinse (ER)
Number of subjects: 22
Study 29933006 — intervention group
Group type: COMPARATOR
Intervention: OptiBond™ FL (OFL, Kerr)
Number of subjects: 22
Study 29933006 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal™ (SBU, 3 M) with selective‐enamel‐etch (SEE)
Number of subjects: 22
Study 26420732 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-year multi-intervention programme including physical activity, diet, and general health education.
Number of subjects: 3
Study 26420732 — intervention group
Group type: COMPARATOR
Intervention: Control group (Pune controls).
Number of subjects: 3
Study 24954607 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol injection
Number of subjects: 47
Study 24954607 — intervention group
Group type: COMPARATOR
Intervention: Sodium tetradecyl sulfate (STS) injection
Number of subjects: 47
Study 22252206 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentavalent human-bovine reassortant rotavirus vaccine (PRV)
Number of subjects: 1003
Study 22252206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1003
Study 19945804 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI)
Number of subjects: 2876
Study 18300064 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental risk framing
Number of subjects: 2405
Study 18300064 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential presentation of risks
Number of subjects: 2405
Study 18300064 — intervention group
Group type: COMPARATOR
Intervention: Total risk presentation
Number of subjects: 2405
Study 15911729 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate (400 mg once a day)
Number of subjects: 1470
Study 15911729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1470
Study 15911729 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate
Number of subjects: 1470
Study 12896934 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment: two injections of enzyme potentiated desensitisation, each comprising 200 Fishman units of beta glucuronidase, 50 pg 1,3‐cyclohexanediol, 50 ng protamine sulphate, and a mixed inhaled allergen extract in a total volume of 0.05 ml of buffered saline.
Number of subjects: 183
Study 12896934 — intervention group
Group type: COMPARATOR
Intervention: Placebo: two injections of 0.05 ml buffered saline solution.
Number of subjects: 183
Study 10475418 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary revascularization
Number of subjects: 50
Study 10475418 — intervention group
Group type: COMPARATOR
Intervention: On-pump coronary revascularization
Number of subjects: 50
Study 8941526 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming and resistance training combined (SR)
Number of subjects: 7
Study 8941526 — intervention group
Group type: COMPARATOR
Intervention: Resistance training workout (RW)
Number of subjects: 7
Study 8941526 — intervention group
Group type: COMPARATOR
Intervention: Intense interval swimming (SW)
Number of subjects: 7
Study 8941526 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 7
Study 1832920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium 0.15 mg kg-1
Number of subjects: 45
Study 1832920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium 0.2 mg kg-1
Number of subjects: 45
Study 1832920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium 0.2 mg kg-1 over 30 s
Number of subjects: 45
Study 1832920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium infusion at 8-10 micrograms kg-1 min-1
Number of subjects: 45
Study 1832920 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 0.04 mg kg-1
Number of subjects: 45
Study 1832920 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 0.75 mg kg-1
Number of subjects: 45
Study 1832920 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous recovery
Number of subjects: 45
Study 6645210 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocalcemia induced during hemodialysis by employing a dialysate devoid of calcium
Number of subjects: 0
Study 30815897 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondrogenic‐induced mesenchymal stem cells + equine allogeneic plasma
Number of subjects: 12
Study 30815897 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline solution
Number of subjects: 12
Study 27864024 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ HDM SLIT tablet (10,000 JAU)
Number of subjects: 946
Study 27864024 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ HDM SLIT tablet (20,000 JAU)
Number of subjects: 946
Study 27864024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 946
Study 27864024 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ HDM SLIT tablet
Number of subjects: 946
Study 26850270 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tenofovir (TFV)
Number of subjects: 472
Study 26850270 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal tenofovir (TFV)
Number of subjects: 472
Study 26850270 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural measures (FTFI, ACASI, PC)
Number of subjects: 472
Study 26850270 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural measures
Number of subjects: 472
Study 26850270 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral group correlates
Number of subjects: 472
Study 26850270 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal group correlates
Number of subjects: 472
Study 25148718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu AuraOnce™
Number of subjects: 178
Study 25148718 — intervention group
Group type: COMPARATOR
Intervention: LMA-Unique™
Number of subjects: 178
Study 25148718 — intervention group
Group type: EXPERIMENTAL
Intervention: I-Gel™
Number of subjects: 178
Study 25148718 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA-Suprême™
Number of subjects: 178
Study 22361251 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (50,000 IU) given orally once on the day of birth or within the next two days
Number of subjects: 104200
Study 22361251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104200
Study 20647390 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lactoferrin (200 mg/day)
Number of subjects: 148
Study 20647390 — intervention group
Group type: COMPARATOR
Intervention: i.v. iron (125 mg weekly)
Number of subjects: 148
Study 17452390 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacist intervention (two home visits within two to eight weeks of discharge, drug review, symptom self-management, and lifestyle advice)
Number of subjects: 293
Study 17452390 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 293
Study 15476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Folinic acid supplementation during MTX therapy
Number of subjects: 40
Study 15476202 — intervention group
Group type: COMPARATOR
Intervention: Folic acid supplementation during MTX therapy
Number of subjects: 40
Study 15476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Folinic acid supplementation
Number of subjects: 40
Study 15476202 — intervention group
Group type: COMPARATOR
Intervention: Folic acid supplementation
Number of subjects: 40
Study 11535323 — intervention group
Group type: EXPERIMENTAL
Intervention: VAQTA 50-U at 6 months (Group I)
Number of subjects: 283
Study 11535323 — intervention group
Group type: EXPERIMENTAL
Intervention: VAQTA 50-U at 12 months (Group II)
Number of subjects: 283
Study 11535323 — intervention group
Group type: EXPERIMENTAL
Intervention: VAQTA 50-U at 18 months (Group III)
Number of subjects: 283
Study 9505927 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg twice daily (n = 19)
Number of subjects: 50
Study 9505927 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg daily (n = 21)
Number of subjects: 50
Study 9505927 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 50
Study 7838448 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute experimental ischaemia
Number of subjects: 58
Study 7838448 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pumping in experimental infarction
Number of subjects: 58
Study 7838448 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of sodium nitroprusside in experimental infarction
Number of subjects: 58
Study 7838448 — intervention group
Group type: COMPARATOR
Intervention: Normal volunteers
Number of subjects: 58
Study 7838448 — intervention group
Group type: COMPARATOR
Intervention: Post-myocardial infarction patients
Number of subjects: 58
Study 3254728 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting quietly
Number of subjects: 115
Study 3254728 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading neutral entertaining material (Herman cartoons)
Number of subjects: 115
Study 3254728 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading stress-relevant questionnaires
Number of subjects: 115
Study 31767543 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for histopathologic diagnosis and Gleason grading
Number of subjects: 25
Study 31820546 — intervention group
Group type: EXPERIMENTAL
Intervention: Vericiguat (soluble guanylate cyclase stimulator)
Number of subjects: 5050
Study 31820546 — intervention group
Group type: COMPARATOR
Intervention: Standard heart failure care (triple therapy)
Number of subjects: 5050
Study 31820546 — intervention group
Group type: COMPARATOR
Intervention: PARADIGM-HF
Number of subjects: 5050
Study 28621326 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltrant combined with flowable composite resin (RI/CR)
Number of subjects: 40
Study 28621326 — intervention group
Group type: COMPARATOR
Intervention: Flowable composite resin (CR)
Number of subjects: 40
Study 26047615 — intervention group
Group type: EXPERIMENTAL
Intervention: Eurythmy therapy A (EYT-A)
Number of subjects: 20
Study 26047615 — intervention group
Group type: EXPERIMENTAL
Intervention: Eurythmy therapy B (EYT-B)
Number of subjects: 20
Study 26047615 — intervention group
Group type: COMPARATOR
Intervention: Control exercise 1 (CE1-A)
Number of subjects: 20
Study 26047615 — intervention group
Group type: COMPARATOR
Intervention: Control exercise 2 (CE2-A)
Number of subjects: 20
Study 26047615 — intervention group
Group type: COMPARATOR
Intervention: Control exercise 1 (CE1-B)
Number of subjects: 20
Study 26047615 — intervention group
Group type: COMPARATOR
Intervention: Control exercise 2 (CE2-B)
Number of subjects: 20
Study 23612620 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal jugular vein catheter placement
Number of subjects: 40
Study 23612620 — intervention group
Group type: COMPARATOR
Intervention: Subclavian vein catheter placement
Number of subjects: 40
Study 23612620 — intervention group
Group type: EXPERIMENTAL
Intervention: Both internal jugular and subclavian vein catheter placements
Number of subjects: 40
Study 21159892 — intervention group
Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg/day
Number of subjects: 105
Study 21159892 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 105
Study 19835475 — intervention group
Group type: EXPERIMENTAL
Intervention: High concentrations of interleukin 15 (IL-15) in breast milk
Number of subjects: 94
Study 19835475 — intervention group
Group type: COMPARATOR
Intervention: Breast milk from HIV-infected women who transmitted HIV
Number of subjects: 94
Study 17353580 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomace olive oil (POO)
Number of subjects: 9
Study 17353580 — intervention group
Group type: COMPARATOR
Intervention: Refined olive oil (ROO)
Number of subjects: 9
Study 12955284 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced amino-acid mixture (BAL)
Number of subjects: 0
Study 12955284 — intervention group
Group type: COMPARATOR
Intervention: TYR-free mixture (absence of tyrosine and phenylalanine)
Number of subjects: 0
Study 11174342 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive approach (cardiac catheterization)
Number of subjects: 202
Study 11174342 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive approach
Number of subjects: 202
Study 9828235 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (IFN-2b) 3 million units (MU) given subcutaneously three times per week for 12 months (group 2)
Number of subjects: 247
Study 9828235 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (IFN-2b) 3 million units (MU) given subcutaneously three times per week for 6 months (group 3)
Number of subjects: 247
Study 9828235 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa-2b (IFN-2b) 3 million units (MU) given subcutaneously three times per week for 6 months (group 1)
Number of subjects: 247
Study 7664547 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler echocardiography
Number of subjects: 48
Study 7664547 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypervolemia (5% albumin)
Number of subjects: 48
Study 2653119 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical epidural anesthesia (CEA) with 15 ml of 0.375% bupivacaine and 150 micrograms fentanyl.
Number of subjects: 20
Study 2653119 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA) with 0.2 mg.kg‐1 flunitrazepam, 5 micrograms.kg‐1 fentanyl, intubation with 0.08 mg.kg‐1 vecuronium, and ventilation with nitrous oxide and oxygen (50% each). Further injections of 2 micrograms.kg‐1 fentanyl every 30 min.
Number of subjects: 20
Study 902556 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of alcohol
Number of subjects: 12
Study 902556 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of alcohol
Number of subjects: 12
Study 902556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 902556 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium sensory stimulation
Number of subjects: 12
Study 902556 — intervention group
Group type: EXPERIMENTAL
Intervention: High sensory stimulation
Number of subjects: 12
Study 902556 — intervention group
Group type: EXPERIMENTAL
Intervention: No sensory stimulation
Number of subjects: 12
Study 31466942 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-enabled video-observed treatment
Number of subjects: 0
Study 31466942 — intervention group
Group type: COMPARATOR
Intervention: Directly observed treatment
Number of subjects: 0
Study 28358274 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training program
Number of subjects: 62
Study 28358274 — intervention group
Group type: COMPARATOR
Intervention: Coping skills group
Number of subjects: 62
Study 26114220 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic text-message system
Number of subjects: 149
Study 23934239 — intervention group
Group type: EXPERIMENTAL
Intervention: HCG injection before IUI
Number of subjects: 100
Study 23934239 — intervention group
Group type: COMPARATOR
Intervention: HCG injection after IUI
Number of subjects: 100
Study 20964739 — intervention group
Group type: EXPERIMENTAL
Intervention: valsartan
Number of subjects: 382
Study 19017883 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium-hyperoxia (60:40 He:O2)
Number of subjects: 38
Study 19017883 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 38
Study 17416272 — intervention group
Group type: EXPERIMENTAL
Intervention: Talocrural joint manipulation
Number of subjects: 52
Study 17416272 — intervention group
Group type: COMPARATOR
Intervention: Placebo manipulation
Number of subjects: 52
Study 15502456 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 21
Study 15502456 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 21
Study 15502456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 11454840 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon angioplasty with moderate dissection (group A)
Number of subjects: 256
Study 11454840 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty without moderate dissection (group B)
Number of subjects: 256
Study 11454840 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon angioplasty with stenting (group A)
Number of subjects: 256
Study 11454840 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty without stenting (group A)
Number of subjects: 256
Study 9730451 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical mitomycin C (MMC) 30 mg, weekly for 4 weeks, then monthly for 5 months
Number of subjects: 344
Study 9730451 — intervention group
Group type: COMPARATOR
Intervention: Intravesical bacille Calmette‐Guérin (BCG), weekly for 6 weeks
Number of subjects: 344
Study 7986787 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet for 3.5 months
Number of subjects: 0
Study 7986787 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactovegetarian diet
Number of subjects: 0
Study 7986787 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet
Number of subjects: 0
Study 2487934 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 170
Study 2487934 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine with 1:200,000 epinephrine
Number of subjects: 170
Study 2487934 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine plus 100 micrograms epidural fentanyl
Number of subjects: 170
Study 2487934 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine plus fentanyl plus epinephrine
Number of subjects: 170
Study 8381 — intervention group
Group type: EXPERIMENTAL
Intervention: Three capsules containing 35 mg of ST-1435 (group A)
Number of subjects: 285
Study 8381 — intervention group
Group type: EXPERIMENTAL
Intervention: Four capsules of ST-1435 (group B)
Number of subjects: 285
Study 8381 — intervention group
Group type: EXPERIMENTAL
Intervention: Five capsules of ST-1435 (group C)
Number of subjects: 285
Study 31477190 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Connects postnatal nurse home visiting intervention
Number of subjects: 4777
Study 31477190 — intervention group
Group type: COMPARATOR
Intervention: Services as usual (control)
Number of subjects: 4777
Study 29310375 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical administration of tetracycline ointment every 6 hours for 48 hours postoperatively
Number of subjects: 117
Study 29310375 — intervention group
Group type: COMPARATOR
Intervention: Control group (no topical tetracycline)
Number of subjects: 117
Study 25972817 — intervention group
Group type: EXPERIMENTAL
Intervention: Michael's game (MG)
Number of subjects: 172
Study 25972817 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 172
Study 22494449 — intervention group
Group type: EXPERIMENTAL
Intervention: Medihoney™ dressings
Number of subjects: 121
Study 22184800 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum A (Nicorette Freshfruit)
Number of subjects: 607
Study 22184800 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum N (Nicorette Icy White)
Number of subjects: 607